---
title: "EWTX: EDG-7500 shows promise for HCM, preserving systolic function and improving diastolic relaxation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299770577.md"
description: "EDG-7500, a novel cardiac sarcomere modulator, demonstrated preserved systolic function, improved diastolic relaxation, and significant patient-reported benefits in HCM. Phase 3 trials are planned for late 2026, with further data and regulatory milestones expected in 2027.Original document: Edgewise Therapeutics, Inc. [EWTX] Slides Release — Sep. 22 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-22T12:56:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299770577.md)
  - [en](https://longbridge.com/en/news/299770577.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299770577.md)
generator: "portal-rs"
---

# EWTX: EDG-7500 shows promise for HCM, preserving systolic function and improving diastolic relaxation

EDG-7500, a novel cardiac sarcomere modulator, demonstrated preserved systolic function, improved diastolic relaxation, and significant patient-reported benefits in HCM. Phase 3 trials are planned for late 2026, with further data and regulatory milestones expected in 2027.

Original document: Edgewise Therapeutics, Inc. \[EWTX\] Slides Release — Sep. 22 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [EWTX.US](https://longbridge.com/en/quote/EWTX.US.md)

## Related News & Research

- [Edgewise Therapeutics details preclinical profile of EDG-7500 cardiac sarcomere modulator in hypertrophic cardiomyopathy](https://longbridge.com/en/news/299753733.md)
- [Edgewise Therapeutics doses first patient in Phase 2 EDG-15400 HFpEF trial](https://longbridge.com/en/news/301272560.md)
- [Is Elevance Health (ELV) Still Undervalued Following Strong Earnings And Higher 2026 Guidance?](https://longbridge.com/en/news/302983253.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)
- [Marqeta (MQ) Expands With Square And Coinbase, Is The Stock Still Undervalued?](https://longbridge.com/en/news/302983307.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**